Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Brokerages

Teleflex Incorporated (NYSE:TFX) has been assigned a consensus rating of “Hold” from the twelve brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $152.90.

A number of equities analysts recently commented on TFX shares. Wall Street Zen upgraded Teleflex from a “sell” rating to a “hold” rating in a report on Sunday, August 9th. Piper Sandler reiterated an “overweight” rating and issued a $169.00 price target (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. Truist Financial boosted their price objective on shares of Teleflex from $143.00 to $150.00 and gave the company a “hold” rating in a research report on Monday, August 10th. Needham & Company LLC raised their target price on shares of Teleflex from $159.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, August 25th. Finally, BMO Capital Markets began coverage on shares of Teleflex in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 target price for the company.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Kelleher Financial Advisors purchased a new position in shares of Teleflex in the 2nd quarter valued at approximately $25,000. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares in the last quarter. Allworth Financial LP bought a new stake in shares of Teleflex during the 2nd quarter valued at $44,000. Hantz Financial Services Inc. grew its position in shares of Teleflex by 40.5% in the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after buying an additional 113 shares during the period. Finally, Versant Capital Management Inc grew its position in shares of Teleflex by 573.4% in the 2nd quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock worth $55,000 after buying an additional 367 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $128.82 on Friday. The company has a market cap of $5.46 billion, a price-to-earnings ratio of -5.53, a price-to-earnings-growth ratio of 0.87 and a beta of 0.82. The company has a 50-day moving average price of $135.55 and a 200-day moving average price of $128.35. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. Teleflex has a 12 month low of $100.18 and a 12 month high of $145.00.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. During the same period in the prior year, the business posted $3.73 earnings per share. Teleflex’s revenue for the quarter was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts anticipate that Teleflex will post 7.26 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a $0.34 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s dividend payout ratio (DPR) is -5.84%.

Teleflex Company Profile

Teleflex Incorporated is a global medical technology company that develops, manufactures and supplies specialty medical devices for hospitals, clinicians and other health care providers. Its products are designed to support procedures in areas including vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgery and urology.

The company’s portfolio includes Arrow branded vascular access and catheter products, airway management devices, regional anesthesia products, surgical instruments, interventional devices and urological products.